Blood coagulation and the risk of atherothrombosis: a complex relationship

AUTOR(ES)

Spronk, Henri MH

FONTE

BioMed Central

RESUMO

The principles of Virchov's triad appear to be operational in atherothrombosis or arterial thrombosis: local flow changes and particularly vacular wall damage are the main pathophysiological elements. Furthermore, alterations in arterial blood composition are also involved although the specific role and importance of blood coagulation is an ongoing matter of debate. In this review we provide support for the hypothesis that activated blood coagulation is an essential determinant of the risk of atherothrombotic complications. We distinguish two phases in atherosclerosis: In the first phase, atherosclerosis develops under influence of "classical" risk factors, i.e. both genetic and acquired forces. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor – factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. The dominant effect of coagulation in this phase is anticoagulant, i.e. thrombin enhances protein C activation through its binding to endothelial thrombomodulin.

Documentos Relacionados

• Interventional procedures for atherothrombosis: pathology of retrieved material
• Viral infections and atherothrombosis: Another caution in the wake of COVID-19?
• The relationship between blood pressure and biochemical risk factors in a general population.
• The Chemistry of Blood Coagulation
• Blood Coagulation and the Clinical Pathologist